Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Deep convolutional neural networks (CNNs) can be trained to predict sequence types for brain MR images, according to new research published in the Journal of Digital Imaging.
Regina Barzilay, PhD, a professor at the Massachusetts Institute of Technology, has been working closely with AI technologies to improve breast cancer care ever since she was diagnosed with the disease in 2014.
A lung cancer researcher from Dartmouth College has received a $1.5 million grant from the National Cancer Institute to build and validate machine leaning approaches to develop better, more personalized cancer treatments.
The combination of machine learning and ultrasound could help healthcare providers with the diagnosis of thyroid nodules, according to new findings published in JAMA Otolaryngology.
Biogen, a biotech company based in Massachusetts, is planning to seek approval from the FDA for an experimental drug that targets the underlying causes of Alzheimer’s disease.
Discussions about AI and radiology often focus on the researchers who help develop the algorithms and radiologists themselves. But a new analysis published in Academic Radiology shines a light on another key role in the implementation of AI: the imaging informaticist.
Deep learning neural networks can improve the detection of tuberculosis (TB) and provide health systems with considerable cost savings, according to new findings published in Scientific Reports.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.